Comments
Loading...
Inovio Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:INO | Benzinga
Inovio Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-1.080
Quarterly Revenue Estimate
$100.00K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$217.76K
Analyze the earnings history of Inovio Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INO | Inovio Pharmaceuticals | -$1.31 | -$1.08 | — | — | $0.00 | $100.00K | — | — | 05/12/2025 | Get Alert |
| INO | Inovio Pharmaceuticals | -$1.10 | -$0.83 | -$0.65 | 21.69% | $103.00K | $25.00K | $117.00K | 368.00% | 03/18/2025 | Get Alert |
| INO | Inovio Pharmaceuticals | -$1.56 | -$1.13 | -$0.89 | 21.24% | $388.45K | $104.50K | $0.00 | -100.00% | 11/14/2024 | Get Alert |
| INO | Inovio Pharmaceuticals | -$1.61 | -$1.10 | -$1.19 | -8.18% | $225.97K | $120.00K | $100.76K | -16.03% | 08/08/2024 | Get Alert |
| INO | Inovio Pharmaceuticals | -$1.89 | -$1.00 | -$1.31 | -31.00% | $114.94K | — | $0.00 | — | 05/13/2024 | Get Alert |
| INO | Inovio Pharmaceuticals | -$2.64 | -$1.27 | -$1.10 | 13.39% | $125.00K | $340.00K | $103.00K | -69.71% | 03/06/2024 | Get Alert |
| INO | Inovio Pharmaceuticals | -$1.80 | -$1.56 | -$1.56 | 0.00% | $9.15M | $120.00K | $388.45K | 223.71% | 11/09/2023 | Get Alert |
| INO | Inovio Pharmaceuticals | -$5.52 | -$1.68 | -$1.56 | 7.14% | $784.39K | $260.00K | $225.97K | -13.09% | 08/09/2023 | Get Alert |
| INO | Inovio Pharmaceuticals | -$4.32 | -$1.68 | -$1.92 | -14.29% | $199.07K | $270.00K | $114.94K | -57.43% | 05/10/2023 | Get Alert |
| INO | Inovio Pharmaceuticals | -$6.00 | -$2.04 | -$2.64 | -29.41% | $839.00K | $340.00K | $125.00K | -63.24% | 03/01/2023 | Get Alert |
| INO | Inovio Pharmaceuticals | -$3.48 | -$3.60 | -$1.80 | 50.00% | $291.70K | $620.00K | $9.15M | 1376.45% | 11/08/2022 | Get Alert |
| INO | Inovio Pharmaceuticals | -$4.68 | -$3.72 | -$5.52 | -48.39% | $272.82K | $520.00K | $784.39K | 50.85% | 08/09/2022 | Get Alert |
| INO | Inovio Pharmaceuticals | -$3.24 | -$4.08 | -$4.32 | -5.88% | $371.12K | $670.00K | $199.07K | -70.29% | 05/10/2022 | Get Alert |
| INO | Inovio Pharmaceuticals | -$1.68 | -$3.84 | -$6.00 | -56.25% | $5.58M | $2.84M | $839.00K | -70.46% | 03/01/2022 | Get Alert |
| INO | Inovio Pharmaceuticals | -$3.12 | -$3.96 | -$3.48 | 12.12% | $236.18M | $970.00K | $291.70K | -69.93% | 11/09/2021 | Get Alert |
| INO | Inovio Pharmaceuticals | -$2.40 | -$3.00 | -$4.68 | -56.00% | $267.19K | $1.21M | $272.82K | -77.45% | 08/09/2021 | Get Alert |
| INO | Inovio Pharmaceuticals | -$3.12 | -$2.16 | -$3.24 | -50.00% | $1.33M | $850.00K | $371.12K | -56.34% | 05/10/2021 | Get Alert |
| INO | Inovio Pharmaceuticals | -$4.56 | -$2.64 | -$1.68 | 36.36% | $279.00K | $1.11M | $5.58M | 402.79% | 03/01/2021 | Get Alert |
| INO | Inovio Pharmaceuticals | -$3.00 | -$2.28 | -$3.12 | -36.84% | $866.86K | $3.05M | $236.18M | 7643.54% | 11/09/2020 | Get Alert |
| INO | Inovio Pharmaceuticals | -$3.60 | -$2.04 | -$2.40 | -17.65% | $135.67K | $2.61M | $267.19K | -89.76% | 08/10/2020 | Get Alert |
| INO | Inovio Pharmaceuticals | -$3.60 | -$2.64 | -$3.12 | -18.18% | $2.83M | $1.91M | $1.33M | -30.52% | 05/11/2020 | Get Alert |
Inovio Pharmaceuticals (INO) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-18 | $-0.65 | $-0.83 | 21.7 % |
| Q3 | 2024-11-14 | $-0.89 | $-1.13 | 21.2 % |
| Q2 | 2024-08-08 | $-1.19 | $-1.10 | -8.18 % |
| Q1 | 2024-05-13 | $-1.31 | $-1.00 | -31.0 % |
Inovio Pharmaceuticals (INO) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-18 | $117.00K | $25.00K | 368.0 % |
| Q3 | 2024-11-14 | $0 | $104.50K | -100.0 % |
| Q2 | 2024-08-08 | $100.76K | $120.00K | -16.0 % |
| Q4 | 2024-03-06 | $103.00K | $340.00K | -69.7 % |
FAQ
When is Inovio Pharmaceuticals (NASDAQ:INO) reporting earnings?
Inovio Pharmaceuticals (INO) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 18, 2025 for Q4.
What were the latest earnings per share (EPS) for Inovio Pharmaceuticals (NASDAQ:INO)?
The Actual EPS was $-0.65, which beat the estimate of $-0.83.
What were Inovio Pharmaceuticals’s (NASDAQ:INO) revenues?
The Actual Revenue was $117K, which beat the estimate of $25K.
Browse earnings estimates, EPS, and revenue on all stocks.